emergency medicine
A 57-year-old woman with metastatic breast cancer
It's Metastatic Breast Cancer Quiz Time with Med-Challenger!
Breast fat necrosis can mimic cancer, including skin retraction, but is benign and not a cancer risk. High-yield board review with distractors.
Fat necrosis is a benign breast condition that can mimic cancer clinically and on imaging, including causing skin retraction.
Question - Fat necrosis
During a routine annual physical exam a 43-year-old woman is found to have a mass in the right breast. Mammography reveals a suspicious mass. A biopsy of the lesion reports fat necrosis.
Which of the following statements concerning fat necrosis of the breast are true?
Answer Options:
A. Fat necrosis results in a diffuse, poorly defined mass
B. Fat necrosis may be accompanied by skin retraction
C. Fat necrosis confers a twofold increased risk of subsequent infiltrating lobular carcinoma
D. Most women relate the tender breast mass to a breast trauma in the previous two to four weeks
Fat necrosis commonly follows trauma, surgery, radiation, anticoagulation-related hematoma, or inflammation—and it can feel and look like breast cancer. On boards, the key is recognizing that skin tethering/retraction does not automatically equal malignancy; benign entities like fat necrosis can do this.
Another major exam point: fat necrosis is benign and is not a premalignant lesion. If imaging is suspicious or there’s clinical–radiologic discordance, the “standard pathway” reflected in ACR BI-RADS/NCCN diagnostic algorithms is to pursue appropriate tissue diagnosis—consistent with this stem already having biopsy confirmation.
Why This Internal Medicine Question Is Often Missed
- Test-takers over-anchor on “skin retraction = cancer,” missing that fat necrosis can mimic carcinoma.
- Confusion between benign proliferative lesions (some increase risk) vs nonproliferative benign processes like fat necrosis (do not).
- Overestimation of how often patients recall an inciting trauma.
What the Distractors Indicate
| Option | What It Tests / Implies | Why It’s Wrong Here |
|---|---|---|
| Fat necrosis results in a diffuse, poorly defined mass y | Malignancy-like “ill-defined/diffuse” infiltrative mass | Fat necrosis typically presents as a localized palpable lesion; while imaging can look spiculated, the classic teaching is not “diffuse poorly defined mass” as a defining feature. |
| Fat necrosis may be accompanied by skin retraction | Clinical mimicry of carcinoma | Correct: fat necrosis can cause skin retraction/tethering and mimic cancer clinically and radiographically. |
| Fat necrosis confers a twofold increased risk of subsequent infiltrating lobular carcinoma | Whether fat necrosis is a premalignant/risk lesion | Incorrect: fat necrosis is benign and does not confer a known increased risk of carcinoma. |
| Most women relate the tender breast mass to a breast trauma in the previous two to four weeks | Recall of antecedent trauma | Incorrect: many patients do not recall trauma (or the timing is variable); history of trauma is supportive but often absent. |
Internal Medicine High-Yield Pearl for Exam Prep
A palpable breast mass with skin retraction can still be benign (e.g., fat necrosis), but suspicious imaging/discordance must follow BI-RADS/NCCN diagnostic pathways to tissue diagnosis.
Core Learning Objectives
- Distinguish the typical clinical/imaging presentation of breast fat necrosis from malignant breast lesions.
- Identify that fat necrosis is benign and does not increase subsequent breast cancer risk.
The Exam “Test Trick” at Play
The item exploits a common heuristic—“retraction means cancer”—and tests whether you can keep a broad differential and remember that certain benign processes (notably fat necrosis) can produce carcinoma-like physical and mammographic findings.
Additional Internal Medicine Practice Questions and Remediation for Breast Fat Necrosis
Internal Medicine Practice Question 1 — Post-procedure mass
A 52-year-old woman develops a firm palpable breast mass 2 months after lumpectomy. Mammogram shows calcifications; ultrasound suggests an oil cyst. Which statement is most accurate?
- A. This finding strongly predicts invasive carcinoma
- B. Fat necrosis is a benign process that can mimic malignancy on imaging
- C. It is a high-risk lesion requiring chemoprevention
- D. It indicates inflammatory breast cancer until proven otherwise
- E. It typically presents as a diffuse bilateral process
Internal Medicine Practice Question 2 — Skin tethering differential
A 45-year-old has a palpable breast mass with mild skin dimpling. She has a history of blunt breast trauma months ago. Which diagnosis can explain dimpling while still being benign?
- A. Fibroadenoma (always freely mobile, cannot dimple)
- B. Fat necrosis
- C. Paget disease
- D. DCIS (never palpable)
- E. Benign cyst (cannot cause any skin change)
Internal Medicine Practice Question 3 — Cancer risk counseling
A patient asks if biopsy-proven fat necrosis increases her future breast cancer risk. Best response?
- A. Yes, risk doubles; start MRI screening
- B. Yes; consider tamoxifen prophylaxis
- C. No; fat necrosis is benign and does not increase breast cancer risk
- D. Yes; schedule prophylactic mastectomy consult
- E. Yes; repeat biopsy every 6 months indefinitely
Internal Medicine Practice Question 4 — When to biopsy
A 48-year-old has a new breast lump. Mammogram is BI-RADS 5. She reports recent trauma and you suspect fat necrosis. Best next step?
- A. Reassure and follow in 2 years
- B. Treat with antibiotics
- C. Tissue diagnosis (core needle biopsy) despite trauma history
- D. Start endocrine therapy
- E. No further workup if ultrasound shows a mass
Internal Medicine Practice Question 5 — Typical history feature
Which history feature is most consistent with fat necrosis (though not always present)?
- A. Prior breast surgery or trauma
- B. Cyclic bilateral breast pain only
- C. Nipple discharge that is milky and bilateral
- D. Progressive unilateral peau d’orange with fever
- E. Palpable axillary nodes as the only finding
Mini Case Discussion Prompt
How would your diagnostic approach differ between (1) a patient with a new palpable mass and BI-RADS 5 imaging who reports trauma and (2) a patient with biopsy-proven fat necrosis and reassuring concordant imaging?
Mini-FAQ
Q1: Can fat necrosis cause skin dimpling or retraction similar to cancer?
A: Yes. Board exams (e.g., ABIM-style questions) expect recognition that fat necrosis can create fibrosis and tethering, mimicking carcinoma on exam.
Q2: Does fat necrosis increase the risk of future breast cancer?
A: No. It’s a benign, nonproliferative process; malignancy risk counseling should reflect that it does not itself confer elevated risk.
Q3: If trauma history suggests fat necrosis, can you skip biopsy when imaging is suspicious?
A: No. The exam-relevant rule is that suspicious imaging (e.g., BI-RADS 4/5) follows diagnostic algorithms (ACR BI-RADS/NCCN) that typically require tissue diagnosis.
Q4: Why is this a “most missed” concept?
A: Many test-takers equate retraction with malignancy and overvalue trauma recall; exams test whether you know benign mimics still require proper diagnostic workup.
This question appears in Med-Challenger Internal Medicine Review with CME
Try for free and save. Ace your exams and meet your CME/MOC requirements for just $35 a month!
No matter your program, no matter the size, Med-Challenger for Groups and Institutions can better prepare your program or group, fulfill industry requirements, and increase test scores.
For personal medical education that includes board's prep, MOC, and CME requirements, Med-Challenger has you covered in Family Medicine, Emergency Medicine, Internal Medicine, Pediatrics, Pediatric Emergency Medicine, OBGYN, Physician Assistants, and Nurse Practitioners.Never miss a thing. Subscribe to our blog and save!
